STUDresearch · Peptide
SNAP-8
Also known as
Acetyl Octapeptide-3 · SNAP8 · Snap-8 · SNAP-8™ peptide solution C (Lipotec / Lubrizol trade form) · SNAP-8 Amide (trade-form discussions) · Acetyl Glutamyl Heptapeptide-1 / -3 (INCI/cross-name discussions — naming inconsistent across vendors) · Ac-Glu-Glu-Met-Gln-Arg-Arg-Ala-Asp-NH₂
Community talk. May be wrong. Not medical advice. Not a protocol. Not for human or animal use.
Peptide
Some talk
Local
Topical
Skin, hair & tissue remodeling
Local — a face serum, not a whole-body shot.
What people say
SNAP-8 is acetyl octapeptide-3, a synthetic cosmetic peptide used in topical products for expression-line appearance. The frequently cited evidence comes mainly from a small manufacturer panel, not an independent monotherapy trial.
Doses people talk about
Rows describe topical formulation or report contexts. They are not injectable doses, and community powder-vial amounts cannot be compared without the finished-product volume and actual product assay.
How it may feel
SNAP-8 usually has no dependable acute sensation. Inspected accounts ranged from visible softening after about three weeks to improvement or no change after two months; the positive reports used other peptides or dermarolling, so SNAP-8-only attribution is weak.
Inspected long-term stacked report10 mg vial content in an unspecified serum bottle, used twice daily
The author combined SNAP-8 with Matrixyl and Argireline for a year and reported change after three weeks; missing final volume and assay preclude concentration comparison.
Supplier formulation convention3–10% of the supplied solution in a finished topical
The denominator is the commercial solution; the active peptide fraction is much smaller than the headline percentage.
Manufacturer panel exposure10% of supplied solution, applied twice daily for 28 days
Seventeen women applied a periorbital cream in a small uncontrolled manufacturer study; this was not 10% pure peptide.
Half-life & effect duration
- Half-life in the body
- Topical SNAP-8No settled estimate
- Felt duration people report
- Positive appearance reportsChanges around 3–8 weeks
- Other accountsNo effect with ongoing use
Cycles people discuss
This is usually discussed as an ongoing once- or twice-daily topical, not an injectable cycle. Four-week checks mirror the manufacturer panel; longer maintenance stories are uncontrolled and often overlap with Botox or other actives.
Timing
Community topical routines use morning/evening application on clean, dry skin before heavier creams. Some separate strong acids, high-pH actives or low-pH vitamin C from the peptide step. These are reported skincare-layering habits, not a systemic or injection schedule.
Stacks
Argireline, Leuphasyl and Syn-Ake commonly appear in the same topical products as SNAP-8. Those combinations may be practical formulation patterns, but they prevent attributing a reported result to SNAP-8 alone.
Watch for
Local irritation: Mild redness, stinging, tingling, or dryness — more often blamed on vehicle, acids, retinoids, or high load than the peptide alone.
Tap a line to jump into the full notes. Research only — may be wrong.
Timing context & sources
Half-life in the body
A systemic human parent-plasma half-life is not an established consumer clock for topical SNAP-8.
The reviewed product literature and reports concern local application; the dossier supplies a 28-day appearance-assessment window rather than systemic pharmacokinetics.
This does not establish local skin residence, penetration, degradation or effect persistence after stopping.
- Historical Lipotec SNAP-8 technical dossier — in-vivo anti-wrinkle efficacy of acetyl octapeptide-3 (third-party mirror) (opens in a new tab)Technical material describes a cream containing 10% SNAP-8 solution applied twice daily around the eyes of 17 women for 28 days, with silicone-imprint profilometry.Historical Lipotec manufacturer-controlled, small and uncontrolled panel accessed through a third-party mirror; supplied-solution percentage is not pure-peptide percentage and no systemic PK was measured.
- Reddit r/PeptideDiscussion — SNAP peptide (opens in a new tab)Multiple authors describe topical use; one reports a 10 mg vial mixed into a Matrixyl/Argireline serum, twice daily for a year, with perceived change around three weeks.Anonymous reports, unspecified final volume and assay, multiple active ingredients, no standardized photographs or control.
- Reddit r/BodyHackGuide — Snap 8 experiments lets hear them (opens in a new tab)One two-month quad-serum user reported thinner forehead lines, another stacked user reported improvement, and a separate twice-daily dermarolling user reported no effect after two months.Anonymous multi-author discussion with different combinations, procedures, concentrations and product identities; no controlled comparison.
Felt duration people report
Community reports disagree on whether visible line changes appear over three to eight weeks.
One year-long stacked-serum user reported noticing changes around three weeks; in another discussion, a two-month stacked user reported improvement and a separate twice-daily user reported no effect.
Anonymous reports used different bases, concentrations, stacks and skin procedures; they do not measure local residence or isolate SNAP-8.
- Reddit r/PeptideDiscussion — SNAP peptide (opens in a new tab)Multiple authors describe topical use; one reports a 10 mg vial mixed into a Matrixyl/Argireline serum, twice daily for a year, with perceived change around three weeks.Anonymous reports, unspecified final volume and assay, multiple active ingredients, no standardized photographs or control.
- Reddit r/BodyHackGuide — Snap 8 experiments lets hear them (opens in a new tab)One two-month quad-serum user reported thinner forehead lines, another stacked user reported improvement, and a separate twice-daily dermarolling user reported no effect after two months.Anonymous multi-author discussion with different combinations, procedures, concentrations and product identities; no controlled comparison.
What people say
- Expression lines: Softens look of forehead, glabella/frown lines, and crow’s feet with consistent twice-daily topical use. forum
- Timeline community: Some notice softer morning creases by ~2 weeks; fuller before/after judgment commonly parked at ~28 days and re-checked at 6–8 weeks. forum
- Needle-free interest: Used as daily topical while delaying, spacing, or “maintaining between” neuromodulator appointments — confounded and not clinical standard. forum
- Best fit narrative: Early/dynamic expression lines more than deep static creases, volume loss, or photoaging texture. forum
- Stack confound: Often co-formulated with Argireline, Leuphasyl, Syn-Ake, Matrixyl, HA, niacinamide — single-agent credit is unreliable. forum
- Null / mixed reality: Community logs split among noticeable softener, subtle/uncertain, and no visible difference — vehicle strength and photo consistency dominate debates. forum
- Maker crow’s-feet panel (widely cited): 10% SNAP-8 solution, ~4 weeks; mean wrinkle-depth drop ~34.98% (n≈17 in dossier-style summaries); maximum reported reduction ~63.13% in best responders. trial
- Other marketed % figures: Vendor/tech materials also circulate “up to ~38%” at 28 days, ~21% at ~7 days, and Lubrizol-style “up to ~72% max wrinkle depth” claims — numbers vary by metric and marketing deck. trial
- Independent-toned summaries: Some reviews put profilometry-style reductions more modestly in roughly the ~11–26% band after ~28 days of 3–10% solution use — still study-dependent. trial
- Vs Argireline: In-vitro + maker in-vivo talk often claims SNAP-8 ~30% more active than parent Argireline at comparable assay loads; head-to-head independent human superiority is thinly proven. trial
- In-vitro hook: Reduced SNARE assembly / catecholamine release and muscle-cell contraction markers vs vehicle in chromaffin-cell and related assays. lab
Doses people talk about
- Pure-peptide math (illustrative): At 0.05% active in the stock solution, a 3–10% formula use rate lands roughly ~15–50 μg/mL pure peptide in the finished product — DIY/literature comparisons often miss this. forum
- Sensitive start: Some start once daily or at the lower ~3–5% solution band before ramping. forum
- DIY powder vs solution confusion (major): Research vials are often 10 mg lyophilized; community % math for pure powder is concentration (%) ≈ peptide mass (mg) ÷ base volume (mL) ÷ 10. forum
- DIY pure-powder examples discussed: 10 mg → 10 mL ≈ 0.1%; 100 mg → 10 mL ≈ 1%; ~300 mg → 10 mL ≈ 3% — reaching commercial “feel” of 3–10% pure powder takes large peptide mass and is not the same as 3–10% of dilute stock. forum
- DIY beauty-supply recipe talk: Some formulators target ~5–8% of powder-style “active” into HA/water bases with preservative and pH check — numbers vary wildly and often ignore the stock-solution convention. forum
- Injectable sidebar — vendor SQ charts (contested): Some peptide-vendor pages list daily SQ ladders like ~330 mcg → ~500 mcg → ~1000 mcg over multi-week blocks; other research write-ups explicitly state there is no validated injectable protocol and treat SQ charts as misapplied. forum
- Finished retail products: Labels and marketing commonly claim ~3–10% SNAP-8 (of the dilute solution convention); true free-peptide delivery rarely third-party verified. forum
- Amount / map: Pea-sized or a few drops to forehead, glabella, and periorbital (crow’s feet), usually twice daily on clean dry skin under moisturizer. forum
- Injectable sidebar — meso-style (not established): Practitioner/community tables sometimes float total ~0.1–0.5 mg per facial session, split across ~4–10 intradermal points at ~0.05–0.1 mL per point, weekly to every 2 weeks then monthly maintenance — anecdote only, no RCT dose. forum
- Uncertainty: Many retail products likely under-deliver vs study loads; purity, label accuracy, and skin permeation of a ~1075 Da hydrophilic peptide remain open community fights. forum
- Commercial solution use rate (formulator standard): Lipotec-style SNAP-8™ peptide solution C recommended at ~3–10% of finished leave-on formula (serums, gels, emulsions). trial
- Critical dilution fact: As supplied, the commercial solution is often ~0.05% pure acetyl octapeptide-3 powder in water + caprylyl glycol — so “10% solution in a cream” is not 10% pure peptide. trial
- Manufacturer panel: A cream containing 10% of the commercial SNAP-8 solution was applied twice daily around the eyes for 28 days in 17 women. The small uncontrolled manufacturer panel measured wrinkle-depth change; it did not test 10% pure peptide. trial
- Framing: Ranges below are discussed cosmetic / research conventions — not advice, prescriptions, or consumption guidance. forum
How it may feel
- Days 1–7: Little line change beyond serum texture/hydration; mild tingling uncommon but reported; irritation not typical at commercial loads. forum
- Weeks 2–8 inspected reports: One author using SNAP-8 in a Matrixyl/Argireline serum twice daily reported seeing line changes after about three weeks and continued for a year. In another discussion, one stacked-serum user reported improvement after two months while a separate twice-daily dermarolling user reported no change after two months. forum
- Weeks 6–12: Maintenance of milder dynamic lines more than progressive dramatic freeze; plateaus common. forum
- After stop: Benefits fade over days to weeks as normal expression returns — continuous presence culture, not a lasting “course effect.” anecdote
- No change by 4–6 weeks: Community checklist — real concentration (solution vs pure powder), vehicle/pH/storage, clean-dry apply, photo lighting/angle, and whether goals need toxin or collagen actives. forum
- Marketing early readout: Some decks cite ~7-day wrinkle-metric movement (~20% range); community treats early photos as noisy. trial
- Week 4 (~28 days): Main brand-study / before-after checkpoint for crow’s feet & forehead in cosmetic panels. trial
- Realistic independent-toned framing: Quality formulas, consistent use → often discussed as modest ~10–30% appearance change at best, not clinic-toxin territory. forum
Cycles people discuss
- Default topical culture: Daily (often AM/PM) serum active — not a classic bodybuilding-style on/off peptide cycle. forum
- Judgment blocks: ~4-week windows match maker study lengths; many wait a second 4-week block before drop/keep. forum
- Longer trial: 6–12 weeks of consistent photos before calling “no effect.” forum
- Event ramp: Some intensify before photos/travel, then lighter maintenance. anecdote
- Between Botox: Topical “bridge/maintenance” talk is common; confounded by residual toxin and concurrent actives. forum
- Around neuromodulator appointments: Some pause topical SNARE peptides briefly so clinic effect can be judged alone. forum
- Long use: Multi-month continuous topical common; long-term high-load registries sparse. forum
- Injectable cadence (sidebar only): Weekly–biweekly loading then monthly touch-ups appear in meso lore — not standardized. forum
- If unclear at ~1 month: Community more often switches vehicle/brand/concentration honesty than “cycles off.” forum
Timing
- Topical PK: No formal human plasma half-life consumers rely on; framed as local skin contact / short local residence. forum
- Why 2× daily: Short surface/residual presence + daily expression load → AM/PM reapplication culture, not weekly dosing. forum
- Appearance lag: Product-on-skin now ≠ multi-week wrinkle-depth photo changes; cumulative attenuation narrative. forum
- Timing tip: Clean dry face before heavier creams; some separate strong acids, high-pH actives, or pure ascorbic acid low-pH layers from peptide steps. forum
- Vs toxin duration: Botulinum effect lasts months post-injection; SNAP-8 needs ongoing topical presence and fades after stop. forum
- Injected tissue unknowns: No published human PK for intradermal SNAP-8 (tissue half-life, NMJ delivery, proteolysis) — dose ranges are empirical. forum
- Storage kills results: Heat, light, oxidation, and bad pH can deaden open serum despite continued “use.” forum
- Penetration debate: MW ~1075 Da exceeds the classic <500 Da rule-of-thumb; hydrophilic peptide skin delivery is a known doubt line in reviews — enhancers, vehicles, microneedle patches discussed. trial
More on what it is
- Why people care: Needle-free “Botox-like” topical niche — milder, reversible expression-line softener vs clinic neuromodulator. forum
- Research lens: Wrinkle-% headlines are formulation- and study-dependent cosmetic data; “10% SNAP-8” usually means % of dilute commercial solution, not pure powder. forum
- What it is: Synthetic 8-amino-acid peptide (acetyl octapeptide-3); Lipotec/Lubrizol SNAP-8™ is an elongation of Argireline (acetyl hexapeptide-8 / hexapeptide-3 family). trial
- Sequence talk: Commonly written Ac-Glu-Glu-Met-Gln-Arg-Arg-Ala-Asp-NH₂; molecular weight often cited ~1075 Da (CAS discussions around 868844-74-0). trial
- Mechanism talk: Mimics N-terminal SNAP-25, competes in SNARE complex assembly → less efficient vesicle fusion / ACh release → attenuated facial micro-contractions in theory. trial
- Vs botulinum toxin: Toxin irreversibly cleaves SNAP-25 (strong, months-long paralysis); SNAP-8 is framed as partial, reversible competitive inhibition — not the same pharmacology. trial
- Evidence honesty: Maker cosmetic panels + in-vitro SNARE/catecholamine assays denser than large independent RCTs; independent write-ups often call SNAP-8-specific efficacy literature thin. trial
- Not this: Not botulinum toxin, not a prescription neuromodulator, not a proven Botox substitute, not a collagen-builder like Matrixyl/GHK-Cu. trial
Stacks
- Argireline + SNAP-8: Dual SNARE-pathway / “expression peptide” pairing — most common commercial and DIY combo; sometimes seen as slight upgrade layering rather than true synergy data. forum
- Leuphasyl (Pentapeptide-18) + SNAP-8: Neuro-modulatory topical pair in many “Botox serum” formulas; enkephalin-path talk for Leuphasyl vs SNARE talk for SNAP-8. forum
- Syn-Ake (dipeptide diaminobutyroyl benzylamide diacetate) + SNAP-8: Snake-venom-mimetic + SNAP-8; community stack notes sometimes float Syn-Ake ~2–4% with SNAP-8 ~3–5% of respective solution stocks — ratios vendor-dependent. forum
- Matrixyl / Matrixyl 3000 (palmitoyl peptide families): Static-line / collagen-signal partners layered with SNAP-8 expression-line talk. forum
- GHK-Cu / copper tripeptide-1: Remodeling + expression-line dual routine; often GHK-Cu as primary tissue active, SNAP-8 as adjunct. forum
- HA / niacinamide / glycerin: Most common non-peptide vehicle partners — hydration and texture can confound wrinkle photos. forum
- Retinoid layering: Same routine OK for many; separate timing (retinoid night, SNAP-8 AM/PM) or buffer moisturizer to limit irritation. forum
- Vitamin C timing: Morning C then peptide, or separate slots — low-pH ascorbic acid co-mix caution for peptide stability. forum
- Kitchen-sink multi-peptide serums: Argireline + SNAP-8 + Leuphasyl + Syn-Ake + Matrixyl + copper — popular retail formula pattern; attribution impossible. forum
- With Botox: Not a pharmacologic stack peer; topical may be used between appointments — toxin remains the stronger NMJ intervention. forum
Storage notes
- No mix instructions here: STUDresearch does not list reconstitution, diluent volumes, or syringe unit charts. People reconstitute many different ways and vial labels differ — that content creates more confusion than clarity. forum
- Storage (general talk only): Unopened research products are usually kept cool, dry, and away from light per the seller label. Anything after first use is product-specific — follow the label, not a universal forum SOP. forum
Watch for
- Local irritation: Mild redness, stinging, tingling, or dryness — more often blamed on vehicle, acids, retinoids, or high load than the peptide alone. forum
- Allergy / contact dermatitis: Infrequent in community reports; patch-test culture in DIY; other formula ingredients often the real culprit. forum
- Eye area migration: Watering/stinging if product runs into the eye; avoid conjunctival contact. forum
- Not Botox safety profile: Lack of toxin-like ptosis lore ≠ proven risk-free at every concentration or route. forum
- Theoretical muscle-weakness talk: Rare speculative worry with chronic high load; no strong clinical signal in topical cosmetic use. anecdote
- Under-dosing / dead-product flop: Many “no result” logs map to weak true peptide load, degraded stock, or photo noise — not proof the mechanism is null. forum
- Expectation gap: Modest dynamic-line soften; deep static lines, laxity, and volume loss need other tools (retinoids, procedures, toxin). forum
- Gray-market inject risks: Infection, endotoxin, mislabeling, sterile-technique failures, dosing errors; cosmetic-grade powder ≠ injectable-grade. forum
- No injectable safety dataset: Practitioner meso doses (e.g. ~0.1–0.5 mg/session lore) lack RCTs; SQ daily charts are not established medicine. forum
- Pregnancy / nursing: Essentially no dedicated safety package — community default is avoid experimental actives. forum
- Source quality: Research powders and serums vary in purity; COA (HPLC identity, endotoxin for any inject-curious use) is a recurring trust filter. forum
- Trademark / marketing overclaim: “Botox alternative” language is commercial framing; evidence and effect size are not toxin-equivalent. trial
Evidence mix
Mostly community / anecdote tags
Full: every bullet (trial + community). Use Scan for a faster bro-science read.